AAAAAA
Results: 1-25/42
Authors:
Dann, EJ
Rowe, JM
Citation: Ej. Dann et Jm. Rowe, Biology and therapy of secondary leukaemias, BEST P R C, 14(1), 2001, pp. 119-137
Authors:
Bleoo, S
Sun, XJ
Hendzel, MJ
Rowe, JM
Packer, M
Godbout, R
Citation: S. Bleoo et al., Association of human DEAD box protein DDX1 with a cleavage stimulation factor involved in 3 '-end processing of pre-mRNA, MOL BIOL CE, 12(10), 2001, pp. 3046-3059
Authors:
Cappelletti, RL
Glinka, CJ
Krueger, S
Lindstrom, RA
Lynn, JW
Prask, HJ
Prince, E
Rush, JJ
Rowe, JM
Satija, SK
Toby, BH
Tsai, A
Udovic, TJ
Citation: Rl. Cappelletti et al., Materials research with neutrons at NIST, J RES NAT I, 106(1), 2001, pp. 187-230
Authors:
Rowe, JM
Citation: Jm. Rowe, Acute leukemia forum 2000 - Advances and Controversies in the Therapy of Acute Myelogenous Leukemia - Introduction, LEUKEMIA, 15(4), 2001, pp. 655-655
Authors:
Rowe, JM
Citation: Jm. Rowe, Uncertainties in the standard care of acute myelogenous leukemia, LEUKEMIA, 15(4), 2001, pp. 677-679
Authors:
Oren, I
Haddad, N
Finkelstein, R
Rowe, JM
Citation: I. Oren et al., Invasive pulmonary aspergillosis in neutropenic patients during hospital construction: Before and after chemoprophylaxis and institution of HEPA filters, AM J HEMAT, 66(4), 2001, pp. 257-262
Authors:
Paietta, E
Neuberg, D
Richards, S
Bennett, JM
Han, L
Racevskis, J
Dewald, G
Rowe, JM
Wiernik, PH
Citation: E. Paietta et al., Rare adult acute lymphocytic leukemia with CD56 expression in the ECOG experience shows unexpected phenotypic and genotypic heterogeneity, AM J HEMAT, 66(3), 2001, pp. 189-196
Authors:
Bennett, JM
Young, MS
Liesveld, JL
Paietta, E
Miller, KB
Lazarus, HM
Marsh, RD
Friedenberg, WR
Saba, HT
Hayes, FA
Dewald, GW
Hiddemann, W
Rowe, JM
Citation: Jm. Bennett et al., Phase II study of combination human recombinant GM-CSF with intermediate-dose cytarabine and mitoxantrone chemotherapy in patients with high-risk myelodysplastic syndromes (RAEB, RAEBT, and CMML): An Eastern Cooperative Oncology Group study, AM J HEMAT, 66(1), 2001, pp. 23-27
Authors:
Rowe, JM
Lazarus, HM
Citation: Jm. Rowe et Hm. Lazarus, Genetically haploidentical stem cell transplantation for acute leukemia, BONE MAR TR, 27(7), 2001, pp. 669-676
Authors:
Tabak, A
Hoffer, E
Rowe, JM
Krivoy, N
Citation: A. Tabak et al., Monitoring of busulfan area under the curve: Estimation by a single measurement, THER DRUG M, 23(5), 2001, pp. 526-528
Authors:
Carter, A
Dann, EJ
Katz, T
Shechter, Y
Oliven, A
Regev, R
Eytan, E
Rowe, JM
Eytan, GD
Citation: A. Carter et al., Cells from chronic myelogenous leukaemia patients at presentation exhibit multidrug resistance not mediated by either MDR1 or MRP1, BR J HAEM, 114(3), 2001, pp. 581-590
Authors:
Zuckerman, E
Zuckerman, T
Sahar, D
Streichman, S
Attias, D
Sabo, E
Yeshurun, D
Rowe, JM
Citation: E. Zuckerman et al., bcl-2 and immunoglobulin gene rearrangement in patients with hepatitis C virus infection, BR J HAEM, 112(2), 2001, pp. 364-369
Authors:
Zuckerman, E
Zuckerman, T
Sahar, D
Streichman, S
Attias, D
Sabo, E
Yeshurun, D
Rowe, JM
Citation: E. Zuckerman et al., The effect of antiviral therapy on t(14;18) translocation and immunoglobulin gene rearrangement in patients with chronic hepatitis C virus infection, BLOOD, 97(6), 2001, pp. 1555-1559
Authors:
Tallman, MS
Andersen, JW
Schiffer, CA
Appelbaum, FR
Feusner, JH
Ogden, A
Shepherd, L
Willman, C
Bloomfield, CD
Rowe, JM
Wiernik, PH
Citation: Ms. Tallman et al., All-trans-retinoic acid maintenance for acute promyelocytic leukemia, HEMAT BLOOD, 40, 2001, pp. 565-569
Authors:
Tallman, MS
Cassileth, PA
Wiernik, PH
Rowe, JM
Citation: Ms. Tallman et al., Treatment of older adults with acute myelogenous leukemia: Studies of the Eastern Cooperative Oncology Group (ECOG), HEMAT BLOOD, 40, 2001, pp. 639-643
Authors:
Fix, RJ
Rowe, JM
McConnell, BC
Citation: Rj. Fix et al., Automation - down to the nuts and bolts, J AUTOM M M, 22(5), 2000, pp. 133-138
Authors:
Rowe, JM
Citation: Jm. Rowe, Concurrent use of growth factors and chemotherapy in acute leukemia, CURR OPIN H, 7(3), 2000, pp. 197-202
Authors:
Lee, S
Tallman, MS
Oken, MM
Cassileth, PA
Bennett, JM
Wiernik, PH
Rowe, JM
Citation: S. Lee et al., Duration of second complete remission compared with first complete remission in patients with acute myeloid leukemia, LEUKEMIA, 14(8), 2000, pp. 1345-1348
Authors:
Elhasid, R
Ben Arush, MW
Pollack, S
Tavor, K
Streichman, S
Postovsky, S
Haddad, N
Rowe, JM
Citation: R. Elhasid et al., Immune and hematopoietic reconstitution after transplantation of cord blood progenitor cells: case report and review of the literature, LEUKEMIA, 14(5), 2000, pp. 931-934
Authors:
Rowe, JM
Citation: Jm. Rowe, Monograph from the Acute Leukemia Forum 1999 on Advances and Controversiesin the Therapy of Acute Myelogenous Leukemia - Introduction, LEUKEMIA, 14(3), 2000, pp. 466-466
Authors:
Rowe, JM
Citation: Jm. Rowe, Treatment of acute myelogenous leukemia in older adults, LEUKEMIA, 14(3), 2000, pp. 480-487
Authors:
Rowe, JM
Citation: Jm. Rowe, NIST's contribution to neutron scattering in materials research, MRS BULL, 25(4), 2000, pp. 6-6
Authors:
Elhasid, R
Ben Arush, MW
Katz, T
Gan, Y
Shechter, Y
Sami, I
Postovsky, S
Reisner, Y
Rowe, JM
Citation: R. Elhasid et al., Successful haploidentical bone marrow transplantation in Fanconi anemia, BONE MAR TR, 26(11), 2000, pp. 1221-1223
Authors:
Ohsuga, Y
Rowe, JM
Liesveld, J
Burns, RP
Gaspari, AA
Citation: Y. Ohsuga et al., Dermatologic changes associated with roquinimex immunotherapy after autologous bone marrow transplant, J AM ACAD D, 43(3), 2000, pp. 437-441
Authors:
Gordon, MS
Young, ML
Tallman, MS
Cripe, LD
Bennett, JM
Paietta, E
Longo, W
Gerad, H
Mazza, J
Rowe, JM
Citation: Ms. Gordon et al., Phase II trial of 2-chlorodeoxyadenosine in patients with relapsed/refractory acute myeloid leukemia - A study of the Eastern Cooperative Oncology Group (ECOG), E5995, LEUK RES, 24(10), 2000, pp. 871-875